211 related articles for article (PubMed ID: 21410736)
21. Impact of restricted reimbursement on the use of statins in Finland: a register-based study.
Martikainen JE; Saastamoinen LK; Korhonen MJ; Enlund H; Helin-Salmivaara A
Med Care; 2010 Sep; 48(9):761-6. PubMed ID: 20706164
[TBL] [Abstract][Full Text] [Related]
22. Use of high-intensity statin therapy with simvastatin 80 mg and atorvastatin 80 mg in primary care.
Meek CL; Reston JD; Ramsbottom T; Pathmanathan H; Viljoen A
Int J Clin Pract; 2011 Feb; 65(2):120-6. PubMed ID: 21235694
[TBL] [Abstract][Full Text] [Related]
23. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
24. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.
Tran YB; Frial T; Miller PS
Can J Clin Pharmacol; 2007; 14(2):e205-14. PubMed ID: 17556788
[TBL] [Abstract][Full Text] [Related]
25. Nonadherence to statin therapy: discontinuation after a single fill.
Lemstra M; Blackburn D
Can J Cardiol; 2012; 28(5):567-73. PubMed ID: 22658124
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
27. Impact of patient and plan design factors on switching to preferred statin therapy.
Cox ER; Kulkarni A; Henderson R
Ann Pharmacother; 2007 Dec; 41(12):1946-53. PubMed ID: 17971409
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of switching from intensive to moderate statin therapy after acute coronary syndromes.
Colivicchi F; Tubaro M; Santini M
Int J Cardiol; 2011 Oct; 152(1):56-60. PubMed ID: 20674999
[TBL] [Abstract][Full Text] [Related]
29. Moving from A to Z: successful implementation of a statin switch program by a large physician group.
Sy FZ; Choe HM; Kennedy DM; Standiford CJ; Parsons DM; Bruhnsen KD; Stevenson JG; Bernstein SJ
Am J Manag Care; 2009 Apr; 15(4):233-40. PubMed ID: 19355796
[TBL] [Abstract][Full Text] [Related]
30. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
[TBL] [Abstract][Full Text] [Related]
31. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
32. Managed care trends in statin usage.
Bazalo GR
Manag Care; 2001 Oct; 10(10):48-50, 53-9. PubMed ID: 11688111
[TBL] [Abstract][Full Text] [Related]
33. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
34. LDL-C goal attainment in patients who remain on atorvastatin or switch to equivalent or non-equivalent doses of simvastatin: a retrospective matched cohort study in clinical practice.
Rublee DA; Burke JP
Postgrad Med; 2010 Mar; 122(2):16-24. PubMed ID: 20203452
[TBL] [Abstract][Full Text] [Related]
35. A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in hypertensive patients without prior cardiovascular disease.
Foody JM; Joyce AT; Jeffers BW; Liu LZ; Benner JS
Am J Ther; 2011; 18(2):110-6. PubMed ID: 20216383
[TBL] [Abstract][Full Text] [Related]
36. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P;
Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
[TBL] [Abstract][Full Text] [Related]
37. Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol.
Aronow HD; Hess G; Hill J; Kuznik A; Liu LZ
Am J Ther; 2010; 17(2):167-75. PubMed ID: 19770794
[TBL] [Abstract][Full Text] [Related]
38. Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland.
Bennie M; Godman B; Bishop I; Campbell S
Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):125-30. PubMed ID: 22280202
[TBL] [Abstract][Full Text] [Related]
39. Effect of statin withdrawal on frequency of cardiac events after vascular surgery.
Schouten O; Hoeks SE; Welten GM; Davignon J; Kastelein JJ; Vidakovic R; Feringa HH; Dunkelgrun M; van Domburg RT; Bax JJ; Poldermans D
Am J Cardiol; 2007 Jul; 100(2):316-20. PubMed ID: 17631090
[TBL] [Abstract][Full Text] [Related]
40. Effects of generic substitution on refill adherence to statin therapy: a nationwide population-based study.
Trusell H; Sundell KA
BMC Health Serv Res; 2014 Dec; 14():626. PubMed ID: 25475416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]